SJS Investment Consulting’s Voyager Therapeutics VYGR Stock Holding History

SJS Investment Consulting’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81	Buy	+23	New	+$87	﹤0.01%	2648

Other funds holding VYGR

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

PFGIA

Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return

HPCM

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SJS Investment Consulting's VYGR Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Voyager Therapeutics (VYGR) in Q2 2026: 23 shares worth $81. The stake represents ﹤0.01% of the portfolio and ranks #2648 among its holdings.

25 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

SJS Investment Consulting held 23 shares of Voyager Therapeutics worth $81 as of Q2 2026.
Voyager Therapeutics was a new SJS Investment Consulting position in Q2 2026.
Voyager Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2648 holding.
25 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.